A glutamate antagonist (receptors, glutamate) used as an anticonvulsant (anticonvulsants) and to prolong the survival of patients with amyotrophic lateral sclerosis. Riluzole is marketed as Rilutek by Sanofi.
For the treatment of amyotrophic lateral sclerosis (ALS, Lou Gehrig's Disease)
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.